4
1. 4. 2023.
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više